“3 Stocks Trading at Rock-Bottom Prices; Analysts Say ‘Buy’”
January 5, 2021
“Esperion (ESPR)…
Overall, Esperion has 6 recent reviews on record, with a breakdown of 5 Buys and 1 Hold to give the stock a Strong Buy rating from the analyst consensus. The shares, trading at $27.16, have an average price target of $63.33, implying a one-year upside of 133%…
Intercept Pharma (ICPT)…
Wall Street is somewhat more divided on the drug maker. ICPT’s Moderate Buy consensus rating is based on 17 reviews, including 8 Buys and 9 Holds. Shares are priced at $25.82, and the average price target of $59.19 suggests an upside potential of 132% for the next 12 months…
Gilead Sciences (GILD)…
What does the rest of the Street think? Looking at the consensus breakdown, opinions from other analysts are more spread out. 10 Buys, 12 Holds and 1 Sell add up to a Moderate Buy consensus. In addition, the $73.94 average price target indicates 25% upside potential from current levels…”
https://finance.yahoo.com/news/3-stocks-trading-rock-bottom-165325984.html